Site Search

The Foundation seeks to advance its mission by making improvements in key areas of health equity and outcomes and diverse workforce development.

The Foundation’s commitment to these principles will continue to be a cornerstone of the Foundation’s work to advance our mission in 2023.

A new inhaled antibiotic for the treatment of cystic fibrosis called Cayston^® is now available for patients through select specialty pharmacies, including the CF Services Pharmacy. 

A key focus of this year's North American Cystic Fibrosis Conference (NACFC) was the progress of the more than 30 potential new therapies moving through the CF Foundation's drug development pipeline.

Bill will jump-start rebuilding of the antibiotics pipeline that is vital to stave off a looming pandemic.